Abstract. The multi-functionality of the DNA mismatch repair (MMR) proteins has been demonstrated by their role in regulation of the cell cycle and apoptosis, as well as DNA repair. Using a unique MSH2 -/-non-tumor human lymphoblastoid cell line we show that MMR facilitates G2/M arrest after UVB-induced DNA damage. Deficiency in MSH2 leads to a decrease in the induction of G2/M cell cycle checkpoint following UVB radiation in MSH2-null non-tumor cells. We also show evidence that the above-mentioned cells deficient in MSH2 have decreased levels of key cell cycle proteins such as CHK1 phosphorylated at Ser345, CDC25C phosphorylated at Ser216 and CDC2 phosphorylated at Tyr15, Thr14, compared to MSH2-proficient cells after UVB radiation. In addition, we demonstrate an altered p53 protein in the MSH2-null cell line. Our data show that the MMR protein MSH2 is involved in the regulation of normal cell cycle response after UVB-induced DNA damage.
Introduction
The DNA mismatch repair (MMR) system ensures replication fidelity by repairing small insertion-deletion loops and single base mismatches involving normal or damaged bases that have not been repaired by DNA polymerase proofreading. Hereditary non-polyposis colorectal cancer (HNPCC) is associated with germline mutations in one of the MMR genes and subsequent loss of MMR function in tumors, while a significant number of sporadic cancers also demonstrate loss of MMR function and genomic instability (1) . These indices exhibit the importance of the MMR proteins in maintaining genomic stability and in the avoidance of tumorigenesis (reviewed in refs. 2, 3) .
In mammals MMR is initiated by the binding of the MSH2-MSH6 heterodimer (MutSα) to base-base mismatches and small loops or the MSH2-MSH3 heterodimer (MutSß) that binds primarily to larger insertion/deletion loops. A second heterodimer consisting of MLH1 bound to PMS2 or MLH3 is subsequently recruited to the mismatched site. The affected DNA strand is cleaved and removal of the mismatch is followed by resynthesis and religation of the DNA strand (reviewed in ref. 4) . In addition to repairing post-replicative errors, MMR can also recognize and remove mispairs involving DNA adducts or chemical modifications produced by exogenous agents, such as O 6 -methylguanine (5) (6) (7) (8) . UVB radiation (290-320 nm) is readily absorbed by DNA, inducing the formation of the DNA lesions cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4 PPs). These photo-lesions are primarily removed by nucleotide excision repair (NER). The role of MMR in post-UV responses remains controversial in part due to the diversity of model organisms, UV dosage employed and recently retracted data (reviewed in ref. 9) . In mammalian cells, the MutS heterodimer binds to UVB-induced mismatch/photoproduct compound lesions (10, 11) . Evidence exists both for and against a role for MMR in the transcription coupled repair of CPDs (reviewed in ref. 9 ). MMR does not participate in the excision and/or repair of photoproducts, but may still be required to counteract the acquisition of mismatches due to error-prone translesion synthesis through these photoproducts, and therefore is important for the suppression of UV-induced mutagenesis and subsequent tumorigenesis.
Recent studies have shown that the MMR proteins are multi-functional, with roles in the regulation of cell cycle, apoptosis, homeologous recombination, as well as DNA repair (reviewed in ref. 12) . Increasing evidence suggests that MMR proteins have a role in recognizing DNA damage and contributing to DNA damage responses independent of repair. Genetic mutants have allowed for the separation of function; MMR mutants defective in apoptosis are still functional in repair and vice versa (13) (14) (15) . Using mouse models or cell lines deficient in MMR, recent findings have suggested a role outside of repair for MMR in the UV-induced DNA damage response (16) (17) (18) (19) (20) . Previous work in our laboratory has shown that primary mouse embryonic fibroblasts (MEFs) and in vivo keratinocytes deficient in Msh2 or Msh6 display lower levels of apoptosis following UVB exposure compared to wild-type cellular controls (17, 21) . This is substantiated by in vivo studies by us and others that have shown that mice deficient for Msh2 or Msh6 develop skin tumors at lower cumulative doses of UVB compared to MMR-proficient littermates (16, 18, 19) , indicating a role for MMR in the cellular DNA damage response after UVB exposure and in prevention of skin cancer.
Recent observations indicate that recognition of UVinduced DNA adducts by sensor proteins, independent of NER, may be the first step in initiating UV-induced cell cycle arrest (22) . Initiation of cell cycle checkpoint occurs rapidly after DNA damage and activation of ATM and ATR. Once active, ATM and ATR activate CHK1 and CHK2 which phosphorylate CDC25C, leading to its inhibition. CDC2 is then phosphorylated by MYT1 and WEE1 to induce G2/M arrest. The removal of these inhibitory phosphates on CDC2 is prevented by CDC25C being inactive, thus inhibiting cell cycle progression into mitosis (reviewed in refs. 23, 24) .
Studies have shown diminished G2/M arrest in the absence of the MMR proteins MSH2, MLH1 or PMS2 in response to treatment by DNA damaging agents such as IR (25) (26) (27) , cisplatin (7,28) and 6-TG (6, 29, 30) . One of the most characterized responses of MMR-deficient cells occurs following DNA damage induced by alkylating agents. Cells defective in MSH2 or MLH1 show no G2 arrest and are resistant to cytotoxicity induced by MNNG (31, 32) . In addition, MMR proteins interact with proteins involved in the G2/M checkpoint pathway. Studies have shown that both Chk1 and Chk2/CHK2 interact with MSH2 (33, 34) and this interaction is enhanced after MNNG exposure (33) . Using normal HeLa nuclear extracts, Wang and Qin demonstrated that MSH2 co-immunoprecipitates with ATR and ATRIP, both of which regulate the downstream phosphorylation of CHK1 (35) .
Many studies that examine the roles of mammalian MMR use HNPCC tumor cell lines as an MMR-deficient model. These cancer cell lines have a mutator phenotype and may have acquired additional genetic alterations affecting their behavior (36) (37) (38) (39) . In contrast we have generated an EBVimmortalized lymphoblastoid cell line derived from normal blood obtained from an individual with bi-allelic MSH2 mutations resulting in an MSH2-null cell line (40) . Despite identification of other MMR-null patients, this cell line is unique as an MSH2 -/-, non-tumor human cell line. By comparing the cell cycle responses of non-tumor cells deficient for MSH2 to MMR-proficient cells, our studies show that MMR plays a role in facilitating G2/M arrest after UVB-induced DNA damage, prior to a neoplastic state. In addition, our studies show altered p53 protein migration in the MSH2-null individual. An altered p53 product has been observed in some but not all MMR-deficient tumor cell lines. Our data provide support that the MMR protein MSH2 is involved in the normal cell cycle response of cells post-UVB. Deficiency in MSH2 leads to decreased induction of cell cycle proteins. Levels of proteins involved in the G2/M pathway were studied after UVB exposure and compared to untreated controls. Protein levels were normalized with respect to the amount of protein loaded and to the signal strength observed in the untreated MSH2 proficient cell line (Fig. 2) . The levels of total CHK1 were lower in untreated KM (MSH2 -/-) cell line compared to the untreated JMG (MSH2 +/+ ) control cell line. Following UVB radiation the levels of total CHK1 were modestly reduced in each of JMG (MSH2 +/+ ) and KM (MSH2 -/-) cell lines compared to their respective untreated controls. CHK1 is activated through phosphorylation by ATM and ATR at residue serine 345 (Ser345). KM (MSH2 -/-) cells showed a decreased level of CHK1 phosphorylated at Ser345 in untreated cells compared to JMG (MSH2 +/+ ) untreated cells. Following UVB radiation the levels of CHK1phos (Ser345) were not as high in KM (MSH2 -/-) cells as JMG (MSH2 +/+ ) cells from 4 to 48 h. KM (MSH2 -/-) cells had sustained levels of CHK1phos (Ser345) from 4 to 24 h after UVB irradiation and returned to basal levels at 48 h (Fig. 2) .
Materials and methods

Cell
The integral driver of the transition between G2 phase and mitosis is the CDC2-cyclin B1 complex. Inhibitory phosphates on CDC2 are removed by CDC25C. Untreated KM (MSH2 -/-) cells had approximately half the amount of CDC25C as (Fig. 2) .
Deficiency in MSH2 leads to decreased induction of p53. The tumor suppressor p53 mediates DNA damage-induced cell cycle arrests at G1, G2/M and S phases (24) . Total p53 levels were analyzed in JMG (MSH2 +/+ ) and KM (MSH2 -/-) cell lines in untreated cells and following UVB radiation (Fig. 3) (Fig. 4) . Protein levels of p21 were decreased in the KM (MSH2 -/-) cell line compared to JMG (MSH2 +/+ ) except at 8 h post-UVB. p21 protein level remained increased in JMG (MSH2 +/+ ) cells up to 48 h after UVB radiation. However, in KM (MSH2 -/-) cells the level of p21 protein was not sustained and returned to normal levels 24 h after UVB radiation. ) . Thus, the difference in the migration pattern of p53 in KM (MSH2 -/-) was not due to a sequence alteration, including the common polymorphism c.347C>G, Pro72Arg in p53 (41, 42) . The p53 protein is extensively modified post-translationally. We found that the slower migration of p53 in the KM (MSH2 -/-) cell line was independent of phosphorylation ( Fig. 6 ) and glycosylation (data not shown). Further analysis of the p53 status in the KM (MSH2 -/-) cell line must be performed to explain the cause of the altered migration of p53 in the KM (MSH2 -/-) cell line. G2/M cell cycle checkpoint showing potential position of MMR is shown in Fig. 7 .
Altered p53 protein migration occurs in other MMR-deficient cell lines and is independent of phosphorylation and glyco-
Discussion
Many studies have indicated the importance of a functional MMR system for the appropriate activation of cell cycle checkpoints in response to several types of DNA damage (34, 35, (43) (44) (45) (46) (47) (48) . However, most of the cell cycle studies have been performed in MMR-deficient tumor cell lines. To ensure that the effects were due to loss of MMR and not to other mutations acquired during tumorigenesis, we assessed the influence of MSH2 in the cell cycle in a non-tumor cell line generated from an individual with bi-allelic MSH2 mutations resulting in an MMR-null phenotype (40 49) . We have previously shown that MMR is important in the prevention of UVB-induced skin cancer via its role in triggering UVB-induced apoptosis (16) . By demonstrating that the lack of MSH2 leads to abrogated G2/M cell cycle arrest as well as altered levels and decreased induction of several integral cell cycle proteins, including p53 post- ATM and ATR are activated after DNA damage. Once active, ATM and ATR phosphorylate and activate CHK1 and CHK2. CHK1/2 phosphorylate and inhibit CDC25C, promoting interaction with 14-3-3 and movement of CDC25C to the cytoplasm. Inhibiting CDC25C prevents the removal of inhibitory phosphates on CDC2 and prevents cell cycle progression into mitosis. CDC2 is phosphorylated at Thr14 and Tyr15 by MYT1 and WEE1 to induce G2/M arrest, but activated by phosphorylation at Thr161. Adapted from (64).
UVB, we have shown that the MMR system is an important component in the cell cycle response of normal, non-tumor cells to UVB-induced DNA damage.
Our data illustrate that an MSH2-deficient non-tumorigenic human cell line shows a significant reduction in the percentage of untreated cells in G2/M phase (p<0.05) and a partial reduction in G2/M arrest 48 (p<0.05) and 72 h (p<0.01) following UVB radiation (Fig. 1A) . Moreover, the foldinduction of cells into G2/M arrest is significantly reduced in KM (MSH2 -/-) cells compared to JMG (MSH2 +/+ ) cells at 72 h post-UVB (1.2-fold induction versus 2-fold induction respectively; p<0.05; Fig. 1B ). These findings are in agreement with previous studies using 6-TG and IR to induce DNA damage (27, 50) . This partial reduction in G2/M arrest is predicted to contribute, along with reduced apoptosis and repair, to the development of neoplasia in the absence of MMR (reviewed in refs. 9,51,52). Our data are consistent with the model that suggests a mechanism by which MMR acts upstream in G2/M arrest and apoptosis following DNA damage. In response to UVB radiation the MMR protein MSH2 binds to DNA lesions and may recruit cell cycle proteins, thus affecting the initiation of the G2/M cell cycle arrest cascade. Studies by Hays et al show that human MutSα and E. coli MutS bind to DNA that contains 'matched' photoproducts [T(CPD)T/AA, T(6-4PP)T/AA] as efficiently as it does to homoduplex DNA (53) . In certain contexts these MMR complexes bind selectively to 'mismatched' photoproducts [T(CPD)T/AG, T(6-4PP)T/AG], but with no excision of the damage. Hays suggests that this formation of 'dead-end intermediates' may be a mechanism for the initiation of signaling by the MMR system.
Our data show a reduction in spontaneous levels of the key cell cycle regulators CHK1, CHK1phos (Ser345), CDC25C, CDC2, and CDC2phos (Tyr15, Thr14) in untreated KM (MSH2 -/-) cells compared to JMG (MSH2 +/+ ) cells. There are also relatively reduced amounts of CHK1phos (Ser345), CDC25Cphos (Ser216), CDC2phos (Tyr15, Thr14) and WEE1 after UVB-induced DNA damage in KM (MSH2 -/-) cells compared to JMG (MSH2 +/+ ) cells. The reduction in CDC2phos (Tyr15, Thr14) in MSH2 deficient cells after UVB-induced DNA damage occurred at timepoints which corresponded to reduced G2/M arrest (Fig. 2) . This is in agreement with Yan et al who determined that MMRdeficient cell lines exhibit rapidly decreasing levels of Cdc2phos (Tyr15) after high doses of IR, which corresponds temporally to IR-induced G2/M arrest (27) . It was previously demonstrated that MSH2 co-immunoprecipitates with ATR and ATRIP, activating CHK1 following MNNG exposure (33, 35) . MMR proteins may behave similarly in response to other DNA damaging agents. Therefore, following UVB radiation MSH2 may directly influence ATR and CHK1 activation, contributing to protein complex formation necessary for ATM/ATR activation and induction of G2/M arrest through the CDC2 pathway. Immunoblots to observe total and activated ATR were also investigated in this study, however due to the high amount of background signal and non-specific banding that occurred no conclusions could be made regarding levels of expression of these proteins in the cell lysates. Support for the recruitment of this pathway was additionally demonstrated by reduction in CHK1phos (Ser345) and CDC25Cphos (Ser216) and WEE1 in MMR deficient cells after UVB treatment (Fig. 2) . However, as MMR deficiency only partially decreases the G2/M cell cycle arrest, ATM/ATR are predicted to be activated by MMR-independent mechanisms as well.
The antibody used to recognize phosphorylated CDC2 (Tyr15) resulted in a reproducible doublet on immunoblots (Fig. 2) . This doublet is most likely due to a second phosphorylation event at Thr14 also associated with inhibition of CDC2. The lower band reflects Tyr15 phosphorylation, and the upper band likely reflects both Thr14 and Tyr15 phosphorylation. A similar pattern was seen with WEE1. The antibody used detects both the unmodified form of WEE1 and the isoform phosphorylated at Ser549 by CHK1. The upper band is associated with phosphorylated WEE1 and the lower band represents the unphosphorylated form of WEE1.
The tumor suppressor p53 is involved in signaling apoptosis and cell cycle checkpoints following exposure to many different endogenous and exogenous DNA damaging agents. Following activation of ATM/ATR, CHK1 and CHK2 phosphorylate p53 at multiple sites, promoting its stabilization and activation (54) (55) (56) . Activated p53 then upregulates 14-3-3 proteins that are involved in the sequestration of CDC2 and CDC25C in the cytoplasm, promoting G2/M arrest (57) . Phosphorylation of p53 at serine 15 is a significant event after UVB exposure. We compared the levels of p53 and activated p53 (Ser15) following UVB irradiation of JMG (MSH2 +/+ ) and KM (MSH2 -/-) cells (Fig. 3) . Both untreated and UVBtreated KM (MSH2 -/-) cells had diminished levels of total p53 compared to JMG (MSH2 +/+ ) cells. The levels of p53phos (Ser15) were near equal at 8 h after UVB radiation between KM (MSH2 -/-) and JMG (MSH2 +/+ ) cell lines, however, at 24 h the levels were greatly decreased with no continued induction of p53phos (Ser15) in the KM (MSH2 -/-) cells. Therefore, MSH2 appears to contribute to the continued induction of the p53 response, but is not required for the initial activation of p53 following UVB radiation. In a recent study, it was demonstrated that phosphorylation of p53 occurred in response to temozolomide (TMZ), and was dependent on a functional MMR system in cells exposed to low drug concentrations (58) . After treatment with methylating agents such as MNNG, MNU, and TMZ, it has been shown that MMR deficient cells do not stabilize p53 via phosphorylation on Ser15 and Ser392. These cells fail to undergo G2/M arrest and also do not undergo apoptosis in response to drug concentrations that effectively kill MMR-proficient cells (43) (44) (45) (46) . In our study, after treatment with UVB Ser15 phosphorylation of p53 still occurred in MMR-deficient cells, although the response was not sustained as in MMR-proficient cells (Fig. 3) . Therefore, MMR proteins are important in p53 phosphorylation and stabilization after UVB-induced DNA damage.
p21 is one of the major downstream transcriptional targets of p53; p21 binds to Cyclin-Cdk complexes, leading to subsequent inhibition of their kinase activity and induction of cell cycle arrest (59, 60) . Levels of UVB-induced p21 accumulation were decreased in the MSH2 -/-cell line KM (24 and 48 h; Fig. 4 -/-) may be an MMRdependent event, but not an MSH2-specific event (Fig. 5) . The p53 cDNA was sequenced in both JMG (MSH2 +/+ ) and KM (MSH2 -/-) cell lines. Sequence analysis demonstrated that both cell lines had identical wild-type sequences for p53 (data not shown), thus the migration difference observed in KM (MSH2 -/-) is not due to a coding mutation or splice site variation. Therefore, the reduced migration in KM (MSH2 -/-) is attributed to altered post-translational modifications. p53 is regulated through many such modifications including phosphorylation, acetylation, methylation, ubiquitination, sumoylation and ribosylation. These processes regulate p53 activation, stabilization, cellular localization and degradation within the cell (reviewed in refs. [61] [62] [63] . Treatment of JMG (MSH2 +/+ ) and KM (MSH2 -/-) cellular lysates with calf intestinal phosphatase showed that the alteration in migration of p53 is independent of phosphorylation (Fig. 6) . Analysis of the glycosylation status of the cell lines revealed that the slower migration of p53 in KM (MSH2 -/-) is also independent of glycosylation; the KM (MSH2 -/-) cell line failed to exhibit increased fluorescence when compared to the MMRcompetent cell lines: JMG, MM and MR (data not shown). It is unlikely that the slower migration is due to ubiquitination or sumoylation because ubiquitin is an 8 kDa protein and SUMO-1 is an 11 kDa protein, which are not consistent with the estimated 4 kDa size increase observed in p53 in KM (MSH2 -/-). The slower migration in p53 in the KM (MSH2 -/-) cell line is likely due to an increase in the smaller covalent modifications. Studies are currently underway to examine acetylation, methylation or ribosylation.
We have demonstrated that lack of MSH2 in human non-tumor lymphoblastoid cells leads to diminished G2/M cell cycle arrest post-UVB and decreased induction of several integral cell cycle proteins, including p53. This evidence establishes that the MMR system is an important component in the cellular response to UVB-induced DNA damage. MMRdeficient cells can still undergo partial G2/M arrest; however, the diminished response may contribute in part to the observation that UVB induces skin tumors at a lower cumulative dose in MMR-null mice than in wild-type (16, 18, 19) . We also analyzed a previously uncharacterized p53 modification that may be MMR-dependent. Our findings, in addition to those by other groups, support a role for MMR in triggering a cascade of events that leads to cell cycle checkpoints post-UVB.
